Free Trial

Russell Investments Group Ltd. Sells 285,867 Shares of VAREX IMAGING $VREX

Varex Imaging logo with Medical background

Key Points

  • Russell Investments Group Ltd. has reduced its stake in Varex Imaging by 60.6%, selling over 285,000 shares during the first quarter, leaving it with approximately 185,745 shares valued at around $2.15 million.
  • Recent analyst reports show mixed ratings for Varex Imaging, with B. Riley raising its price target from $12.00 to $16.00, while Wall Street Zen downgraded its rating from “strong-buy” to “buy”.
  • Varex Imaging's stock is currently trading at $11.40, with an average target price set at $19.50 according to consensus ratings.
  • Five stocks we like better than Varex Imaging.

Russell Investments Group Ltd. lessened its position in VAREX IMAGING (NASDAQ:VREX - Free Report) by 60.6% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 185,745 shares of the company's stock after selling 285,867 shares during the period. Russell Investments Group Ltd. owned approximately 0.45% of VAREX IMAGING worth $2,155,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in VREX. Allspring Global Investments Holdings LLC raised its stake in shares of VAREX IMAGING by 21.0% in the first quarter. Allspring Global Investments Holdings LLC now owns 2,779,412 shares of the company's stock worth $31,769,000 after purchasing an additional 481,537 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of VAREX IMAGING by 4.2% in the first quarter. Vanguard Group Inc. now owns 2,640,127 shares of the company's stock worth $30,625,000 after purchasing an additional 106,412 shares during the last quarter. Cooke & Bieler LP raised its stake in shares of VAREX IMAGING by 18.7% in the first quarter. Cooke & Bieler LP now owns 2,122,683 shares of the company's stock worth $24,623,000 after purchasing an additional 333,794 shares during the last quarter. Royce & Associates LP raised its stake in shares of VAREX IMAGING by 2.1% in the first quarter. Royce & Associates LP now owns 762,733 shares of the company's stock worth $8,848,000 after purchasing an additional 15,963 shares during the last quarter. Finally, Rice Hall James & Associates LLC raised its stake in shares of VAREX IMAGING by 75.2% in the first quarter. Rice Hall James & Associates LLC now owns 575,787 shares of the company's stock worth $6,679,000 after purchasing an additional 247,095 shares during the last quarter.

VAREX IMAGING Stock Performance

Shares of NASDAQ:VREX traded up $0.08 during mid-day trading on Friday, reaching $11.55. The company had a trading volume of 151,509 shares, compared to its average volume of 545,010. The company has a current ratio of 3.51, a quick ratio of 1.82 and a debt-to-equity ratio of 0.78. The firm has a market cap of $479.33 million, a price-to-earnings ratio of -3.60 and a beta of 0.87. The company's 50-day moving average price is $8.91 and its 200-day moving average price is $9.42. VAREX IMAGING has a one year low of $6.76 and a one year high of $16.93.

VAREX IMAGING (NASDAQ:VREX - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.18 EPS for the quarter, topping analysts' consensus estimates of $0.04 by $0.14. The company had revenue of $203.00 million for the quarter, compared to analysts' expectations of $190.32 million. VAREX IMAGING had a negative net margin of 16.13% and a positive return on equity of 5.54%. VAREX IMAGING has set its Q4 2025 guidance at 0.100-0.300 EPS. As a group, equities research analysts anticipate that VAREX IMAGING will post 0.53 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms have recently issued reports on VREX. B. Riley reiterated a "buy" rating and issued a $16.00 target price (up previously from $12.00) on shares of VAREX IMAGING in a research note on Friday, August 8th. Wall Street Zen lowered VAREX IMAGING from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 9th. Two research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, VAREX IMAGING currently has an average rating of "Buy" and an average target price of $19.50.

View Our Latest Stock Analysis on VREX

About VAREX IMAGING

(Free Report)

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.

Featured Stories

Institutional Ownership by Quarter for VAREX IMAGING (NASDAQ:VREX)

Should You Invest $1,000 in Varex Imaging Right Now?

Before you consider Varex Imaging, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.

While Varex Imaging currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.